Chronic Myeloid Leukemia Relapsing 25 Years after Allogenic Stem Cell Transplantation

<div>Development in <i>BCR-ABL1/ABL1</i> transcript levels in the setting of relapsed CML. The figure shows the <i>BCR-ABL1/ABL1</i> transcript levels in peripheral blood for the patient. Time point 0 represents the diagnosis of CML relapse and initiating of imatinib therapy.</div>

Case Reports in Hematology

fig1

Figure 1

Figure 1: Chronic Myeloid Leukemia Relapsing 25 Years after Allogenic Stem Cell Transplantation 